venlafaxine hydrochloride has been researched along with Bilateral Headache in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hedayat, M; Heidari, M; Nazarbaghi, S; Sharifi, H | 1 |
| Barea, LM; Calia, LC; Campos, HC; Carvalho, JJF; Costa, ATNMD; Costa, MENM; Figueiredo, MRCF; Filho, PFM; Fortini, I; Fragoso, YD; Júnior, JAM; Jurno, ME; Kaup, AO; Kowacs, PA; Melhado, EM; Peixoto, PM; Peres, MFP; Piovesan, ÉJ; Queiroz, LP; Rocha-Filho, PAS; Roesler, CAP; Santos, PSF; Sarmento, EM; Segundo, JBA; Silva-Neto, RP; Souza, JA; Souza, MNP; Speziali, JG; Theotonio, GOM | 1 |
| Golding, AN; Houle, TT; Turner, DP | 1 |
| Diukova, GM; Kovalchuk, MO; Semenov, RV; Toropina, GG; Troshneva, A | 1 |
| Bielski, RJ; Chang, CC; Ventura, D | 1 |
| Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Kim, TS; Pae, CU; Rhee, WI; Yoon, SJ | 1 |
| Ahmed, S; Baldwin, D; Benattia, I; Davidson, J; Kuper, E; Musgnung, J; Pedersen, R; Stein, DJ | 1 |
| Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM | 1 |
| Kornstein, SG | 1 |
| Farah, A; Lauer, TE | 1 |
| Haddad, P | 1 |
| Nelson, JC | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Agelink, MW; Klieser, E; Zitzelsberger, A | 1 |
| Boyd, IW | 1 |
| Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J | 1 |
| Abbar, M; Blayac, JP; Giniès, E; Peyrière, H; Pinzani, V; Robert, L | 1 |
5 review(s) available for venlafaxine hydrochloride and Bilateral Headache
| Article | Year |
|---|---|
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Newer antidepressants and the discontinuation syndrome.
Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride | 1997 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Hallucinations; Headache; Humans; Male; Middle Aged; Paresthesia; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2000 |
7 trial(s) available for venlafaxine hydrochloride and Bilateral Headache
| Article | Year |
|---|---|
Venlafaxine can reduce the migraine attacks as well as amitriptyline: A noninferiority randomized trial.
Topics: Adult; Amitriptyline; Drug-Related Side Effects and Adverse Reactions; Female; Headache; Humans; Male; Migraine Disorders; Venlafaxine Hydrochloride | 2022 |
A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 2004 |
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sweating; Venlafaxine Hydrochloride; Weight Gain | 2006 |
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
Topics: Adult; Ambulatory Care; Cyclohexanols; Delayed-Action Preparations; Dizziness; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Humans; Longitudinal Studies; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
6 other study(ies) available for venlafaxine hydrochloride and Bilateral Headache
| Article | Year |
|---|---|
Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II.
Topics: Brazil; Consensus; Headache; Humans; Migraine Disorders; Venlafaxine Hydrochloride | 2022 |
Using a graphical risk tool to examine willingness to take migraine prophylactic medications.
Topics: Amines; Analgesics; Antidepressive Agents; Antihypertensive Agents; Cross-Sectional Studies; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Headache; Humans; Longitudinal Studies; Male; Migraine Disorders; Pain Measurement; Pre-Exposure Prophylaxis; Propranolol; Retrospective Studies; Surveys and Questionnaires; Valproic Acid; Venlafaxine Hydrochloride | 2016 |
[Headaches of tension and psychogenic headaches: assessment of the treatment with venlafaxine].
Topics: Analgesics; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Headache; Humans; Male; Pain Measurement; Stress, Psychological; Tension-Type Headache; Venlafaxine Hydrochloride | 2010 |
Possible venlafaxine withdrawal syndrome.
Topics: Adult; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1996 |
Withdrawal syndrome after discontinuation of venlafaxine.
Topics: Age Factors; Aged; Cyclohexanols; Depressive Disorder; Female; Gastrointestinal Diseases; Headache; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Venlafaxine withdrawal reactions.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1998 |